Clinical Genomics brings home $15M for two-gene colorectal cancer test

Clinical Genomics is vying for a space in the saturated liquid biopsy market, and now it has some funds to help it along the way. The company reeled in $15 million in a Series A round to support development of its genetic test for colorectal cancer.

Sydney, Australia-based VC firm OneVentures led the round.

Learn More

Posted in — Fierce Biotech


You may also like

22 March 2016

Clinical Genomics brings home $15M for two-gene colorectal cancer test

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor